Ana P. M.
- Country
- Spain
- Department
- Neurology
Research Overview
- C0251006 - A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-06823859 IN PARTICIPANTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHIES (INCLUDING PARTICIPANTS WITH ACTIVE DERMATOMYOSITIS OR POLYMYOSITIS)
- Efficacy and Safety of Nipocalimab vs Efgartigimod in a Randomized, Open-label, Phase 3b, Interventional Trial Including Within Class Switching From Efgartigimod to Nipocalimab
Data & Insights
Has run more than one trial at 2 of 42 partner sites.
Specializations
Neuro‑Oncology
Investigation of primary and secondary malignancies of the central nervous system.
- Glioblastoma
- Brain Metastases
- HER2‑Positive Breast Cancer with CNS Involvement
Emphasizes molecularly guided treatment strategies.
Hematologic Malignancies
Study of blood‑derived cancers across acute, chronic and lymphoid spectrums.
- Acute Myeloid Leukemia
- Diffuse Large B‑Cell Lymphoma
- Myelodysplastic Syndrome
Targets genetic and epigenetic drivers of disease progression.
Cardiovascular & Metabolic Disorders
Focus on heart disease, vascular pathology and related metabolic conditions.
- Heart Failure with Reduced Ejection Fraction
- Atherosclerotic Cardiovascular Disease
- Chronic Kidney Disease
Integrates cardiometabolic risk reduction with novel therapeutics.
Hepatic & Gastrointestinal Oncology
Exploration of malignant diseases of the liver, biliary tree and gastrointestinal tract.
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Colorectal Cancer
Addresses tumor heterogeneity and targeted interventions.
Pulmonary & Respiratory Diseases
Research on acute and chronic disorders of the respiratory system.
- Acute Respiratory Distress Syndrome
- Chronic Obstructive Pulmonary Disease
- Asthma
Evaluates inflammatory pathways and novel therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.